查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1680335

球虫药物市场报告：2031 年趋势、预测与竞争分析

Anticoccidial Drug Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

未来全球球虫药物市场很可能在兽医诊所和零售药局市场中看到机会。预计全球球虫药物市场从 2025 年到 2031 年的复合年增长率为 5.7%。这个市场的主要驱动力是球虫的上升、兽医学的发展以及对肉类和家禽产品的需求不断增长。

  • Lucintel 预测，在预测期内，伴同性动物仍将占据动物类别的很大一部分。
  • 在分销管道类别中，兽医诊所预计在预测期内将经历最高的成长。
  • 根据地区来看，预计北美在预测期内将经历最高的成长。

球虫药物市场的策略性成长机会

由于蛋白质需求增加，全球家禽产量持续增加，球虫药物市场预计将显着成长。这种动态格局为产业相关人员提供了众多策略机会。配方创新、向永续实践的转变以及消费者对动物福利意识的提高正在重塑市场动态。利用这些趋势可以帮助公司提高市场地位并满足不断变化的客户需求，因此识别和寻求策略成长机会至关重要。

  • 拓展新兴市场：新兴市场的鸡肉产量正在上升，具有巨大的成长潜力。公司可以探索东南亚和非洲等地区的伙伴关係和分销管道，以满足球虫药物日益增长的需求，从而增加其销售额和市场占有率。
  • 开发新配方：投资研发新配方可以帮助您的产品在拥挤的市场中脱颖而出。透过专注于创新的输送系统和联合治疗，公司能够提高疗效并减少抗药性，满足寻求先进球虫解决方案的种植者的需求。
  • 专注于预防性卫生解决方案：随着产业向预防性卫生策略转变，整合到整体控制计画中的球虫提供了巨大的机会。开发针对球虫同时支持整个牛健康的产品将吸引寻求全面解决方案的生产商。
  • 与技术提供者合作：与科技公司伙伴关係可以透过资料驱动的洞察力和精密农业技术来增强我们的产品供应。将这些技术整合到您的抗球虫解决方案中，将能够提高剂量准确性和羊群监控，最终改善健康并增加销售。
  • 永续产品开发：在产品开发中关注永续性有助于您满足消费者偏好和监管要求。开发环保的植物来源球虫药物不仅能吸引市场兴趣，还能使公司成为永续农业的领导者，刺激长期成长。

球虫药物市场存在多种策略性成长机会，包括扩展到新兴市场、开发新配方、专注于预防性卫生解决方案、与技术提供者合作以及永续产品开发。利用这些手段可以帮助企业提高竞争地位，满足不断变化的市场需求，并在这个快速变化的产业中稳固地位。

球虫药物市场驱动因素与挑战

由于影响生产实践和消费者需求的各种因素，球虫药物市场正在发生重大转变。随着全球家禽消费量的增加，对控制球虫的有效解决方案的需求也日益增加。然而，市场也面临监管压力和消费者偏好变化等挑战。相关人员必须了解驱动因素和挑战，以应对不断变化的情况的复杂性并利用成长机会。

推动球虫药物市场发展的因素有：

  • 增加家禽产量：对家禽产品的需求增加是球虫药物市场的主要动力。随着人口的增长和饮食转向更高的蛋白质消耗，家禽养殖户正在寻找有效的解决方案来确保动物健康和生产力，从而导致球虫药物的需求增加。
  • 提高动物健康意识：动物福利和健康越来越受到消费者和生产者的关注。这种认知正在推动有效球虫药物的采用，因为相关人员的目标是保持羊群健康和生产力，同时确保人道的养殖实践。
  • 对替代药物的监管支持：对牲畜抗生素使用的严格监管正在鼓励替代球虫的开发。这项变化鼓励製造商投资符合新准则的创新解决方案，进一步推动市场成长。
  • 技术进步：配方和药物传输系统的创新提高了球虫药物的有效性。研究开发和技术进步使得能够最大限度减少抗药性的产品的开发成为可能，从而对寻求有效治疗的种植者俱有吸引力。
  • 增加研发投入：对研发的重视程度不断提高，推动了球虫药物市场的创新。公司正在投资研发新的活性成分和联合治疗，不仅是为了满足当前的需求，也是为了在未来保持竞争力。

球虫药物市场面临的挑战是：

  • 监管挑战：不断变化的监管环境给製造商带来了重大挑战。遵守严格的安全性和有效性标准会减慢产品开发时间、增加成本并使新产品进入市场变得复杂。
  • 市场饱和：随着市场的成长，现有公司之间的竞争加剧，这可能导致市场饱和。这种饱和会压低价格并挤压利润率，使公司更难维持永续成长。
  • 消费者偏好的改变：消费者对有机和无抗生素产品的偏好的改变可能会对传统的球虫策略提出挑战。为了满足这些偏好，生产商需要投资新的适应解决方案。

总之，球虫药物市场受到鸡肉产量增加、动物健康意识增强、替代品监管支持、技术进步以及研发投资增加的推动。但他们必须应对监管障碍、市场饱和和消费者偏好变化等挑战。了解这些动态将有助于相关人员应对市场的复杂性并抓住成长机会。

目录

第一章执行摘要

第二章全球球球虫药物市场：市场动态

  • 简介、背景和分类
  • 供应链
  • 产业驱动力与挑战

第三章 2019年至2031年市场趋势及预测分析

  • 宏观经济趋势（2019-2024）及预测（2025-2031）
  • 全球球虫药物市场趋势（2019-2024）及预测（2025-2031）
  • 全球球虫药物市场（依动物类型划分）
    • 家畜
    • 宠物
  • 全球球虫药物市场（依药物类别划分）
    • 球虫防治
    • 球虫
  • 全球球虫药物市场（依药物类别划分）
    • 离子载体
    • 抗生素
    • 磺胺类药物
    • 化学衍生物
    • 其他的
  • 全球球虫药物市场（按分销管道）
    • 兽医诊所
    • 零售药局
    • 其他的

第四章 2019 年至 2031 年市场趋势与预测分析 - 按地区

  • 全球球虫药物市场（按地区）
  • 北美球球虫药物市场
  • 欧洲球球虫药物市场
  • 亚太地区抗球球虫药物市场
  • 世界其他地区球虫药物市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球球虫药物市场的成长机会
    • 全球球虫药物市场的成长机会
    • 全球球虫药物市场的成长机会（按药物类别划分）
    • 全球球虫药物市场按分销管道分類的成长机会
    • 按地区：全球球虫药物市场的成长机会
  • 全球球虫药物市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球球虫药物市场的产能扩张
    • 全球球虫药物市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业简介

  • Zoetis
  • Phibro Animal Health Corporation
  • Huvepharma
  • Elanco
  • Biochem Pharma
  • Ceva
  • Impextraco
  • Virbac
  • Boehringer Ingelheim International
  • MSD Animal Health
简介目录

The future of the global anticoccidial drug market looks promising with opportunities in the veterinary hospital and retail pharmacy markets. The global anticoccidial drug market is expected to grow with a CAGR of 5.7% from 2025 to 2031. The major drivers for this market are the rising prevalence of coccidiosis, growing developments in veterinary medicine, and expanding demand for meat and poultry products.

  • Lucintel forecasts that, within the animal category, companion animals will remain a larger segment over the forecast period.
  • Within the distribution channel category, veterinary hospital is expected to witness the highest growth over the forecast period.
  • In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Anticoccidial Drug Market

The anticoccidial drug market is evolving rapidly, responding to the growing demand for poultry products and increasing concerns about drug resistance and animal welfare. Innovations in formulations and a shift toward sustainable practices are shaping this market. Regulatory changes and consumer preferences are also driving the development of alternative therapies and natural products. As stakeholders adapt to these challenges, several emerging trends are becoming prominent in the anticoccidial landscape.

  • Shift to Natural Products: There is a notable shift toward natural and plant-based anticoccidials as consumers and producers alike seek alternatives to traditional chemical treatments. This trend is fueled by rising awareness of antibiotic resistance and the demand for organic poultry products.
  • Innovation in Formulations: The market is witnessing significant innovations in drug formulations, including the development of new delivery systems and combination therapies. These advancements aim to enhance the efficacy of existing products while minimizing the risk of resistance development among coccidia.
  • Increased R&D Investment: Pharmaceutical companies are ramping up their research and development efforts to discover novel anticoccidial agents. This trend is driven by the need for more effective solutions and the desire to comply with stricter regulations regarding drug use in livestock.
  • Focus on Animal Welfare: Growing awareness of animal welfare issues is prompting producers to adopt more humane farming practices. This shift influences the development of anticoccidials that not only improve health outcomes for poultry but also align with ethical considerations.
  • Regulatory Changes: Stricter regulatory frameworks concerning drug usage and safety are emerging globally. These changes compel manufacturers to enhance their product safety profiles and develop more sustainable and effective anticoccidial solutions to meet compliance requirements.

The anticoccidial drug market is undergoing transformative changes characterized by a move toward natural products, innovative formulations, increased research investment, a focus on animal welfare, and evolving regulatory landscapes. These trends not only address current market demands but also pave the way for a more sustainable and effective approach to managing coccidiosis in livestock.

Recent Developments in the Anticoccidial Drug Market

The anticoccidial drug market is evolving in response to growing challenges such as antibiotic resistance, changing consumer preferences, and stricter regulations. Key players are investing in research and development to create more effective and sustainable solutions. As the demand for poultry products increases globally, advancements in formulations and a focus on animal welfare are shaping the landscape. Understanding these recent developments is crucial for stakeholders aiming to navigate the complexities of the market and adapt to emerging trends.

  • New Drug Approvals: Recent approvals of novel anticoccidial agents have expanded the market, providing poultry producers with more options to combat coccidiosis. These new products often feature improved efficacy and safety profiles, meeting the demand for alternatives to traditional treatments.
  • Enhanced Combination Therapies: The use of combination therapies has gained traction, as they offer synergistic effects against various strains of coccidia. By combining multiple active ingredients, these formulations enhance effectiveness while reducing the likelihood of resistance, making them increasingly popular among producers.
  • Focus on Resistance Management: Addressing antibiotic resistance has become a priority in the anticoccidial market. New strategies, such as rotating different classes of anticoccidials and integrating non-pharmaceutical interventions, are being developed to mitigate resistance and maintain treatment efficacy.
  • Integration of Technology: Advancements in technology, including precision agriculture and data analytics, are influencing the anticoccidial market. Producers are utilizing these tools to optimize dosing regimens and monitor health outcomes, leading to more efficient use of anticoccidials and better flock management.
  • Emphasis on Sustainable Practices: The growing emphasis on sustainability is driving the development of eco-friendly anticoccidials. Companies are increasingly focusing on plant-based formulations and reducing environmental impact, aligning their products with consumer preferences for sustainable and ethically produced food.

The anticoccidial drug market is experiencing significant developments marked by new drug approvals, enhanced combination therapies, a focus on resistance management, the integration of technology, and an emphasis on sustainable practices. These advancements not only respond to current challenges but also position the industry for future growth, ultimately benefiting producers and consumers alike.

Strategic Growth Opportunities for Anticoccidial Drug Market

The anticoccidial drug market is poised for significant growth as global poultry production continues to rise, driven by increasing protein demand. This dynamic landscape presents numerous strategic opportunities for industry players. Innovations in formulations, a shift toward sustainable practices, and growing consumer awareness about animal welfare are reshaping market dynamics. By capitalizing on these trends, companies can enhance their market position and meet evolving customer needs, making it essential to identify and pursue strategic growth opportunities.

  • Expansion into Emerging Markets: There is substantial potential for growth in emerging markets where poultry production is on the rise. Companies can explore partnerships and distribution channels in regions like Southeast Asia and Africa to tap into increasing demand for anticoccidial drugs, boosting sales and market share.
  • Development of Novel Formulations: Investing in research and development to create novel formulations can differentiate products in a crowded market. By focusing on innovative delivery systems and combination therapies, companies can enhance efficacy and reduce resistance, catering to producers looking for advanced solutions to coccidiosis.
  • Focus on Preventive Health Solutions: As the industry shifts toward preventive health strategies, anticoccidial drugs that integrate into holistic management programs present a significant opportunity. Developing products that support overall flock health while targeting coccidiosis can attract producers seeking comprehensive solutions.
  • Collaboration with Technology Providers: Forming partnerships with technology firms can enhance product offerings through data-driven insights and precision agriculture techniques. Integrating these technologies into anticoccidial solutions can improve dosing accuracy and flock monitoring, ultimately leading to better health outcomes and increased sales.
  • Sustainable Product Development: Emphasizing sustainability in product development can align with consumer preferences and regulatory demands. Creating eco-friendly, plant-based anticoccidials can not only capture market interest but also position companies as leaders in sustainable agriculture, driving long-term growth.

The anticoccidial drug market presents several strategic growth opportunities, including expansion into emerging markets, the development of novel formulations, a focus on preventive health solutions, collaboration with technology providers, and sustainable product development. By pursuing these avenues, companies can enhance their competitive edge, respond to evolving market needs, and secure a robust position in this rapidly changing industry.

Anticoccidial Drug Market Driver and Challenges

The anticoccidial drug market is experiencing significant transformation, driven by various factors that influence production practices and consumer demand. As global poultry consumption rises, the need for effective solutions to combat coccidiosis becomes increasingly critical. However, this market also faces challenges such as regulatory pressures and shifting consumer preferences. Understanding both the drivers and challenges is essential for stakeholders aiming to navigate the complexities of this evolving landscape and capitalize on growth opportunities.

The factors responsible for driving the anticoccidial drug market include:

  • Rising Poultry Production: The increasing demand for poultry products is a primary driver of the anticoccidial drug market. As populations grow and diets shift toward higher protein consumption, poultry producers seek effective solutions to ensure animal health and productivity, leading to greater demand for anticoccidials.
  • Growing Awareness of Animal Health: There is a heightened focus on animal welfare and health among consumers and producers alike. This awareness drives the adoption of effective anticoccidial drugs, as stakeholders aim to maintain flock health and productivity while ensuring humane farming practices.
  • Regulatory Support for Alternatives: Stricter regulations on antibiotic use in livestock are encouraging the development of alternative anticoccidial agents. This shift is prompting manufacturers to invest in innovative solutions that comply with new guidelines, further driving growth in the market.
  • Technological Advancements: Innovations in drug formulations and delivery systems are enhancing the efficacy of anticoccidials. Advances in research and technology allow for the development of products that minimize resistance, making them more appealing to producers seeking effective treatments.
  • Increased Investment in R&D: The rising focus on research and development is driving innovation in the anticoccidial market. Companies are investing in the discovery of new active ingredients and combination therapies, which not only meet current demands but also position them competitively for the future.

Challenges in the anticoccidial drug market are:

  • Regulatory Challenges: The evolving regulatory landscape poses significant challenges for manufacturers. Compliance with stringent safety and efficacy standards can slow down product development timelines and increase costs, complicating market entry for new products.
  • Market Saturation: As the market grows, increased competition among existing players can lead to market saturation. This saturation may drive down prices and squeeze profit margins, making it difficult for companies to maintain sustainable growth.
  • Consumer Preference Shifts: Changing consumer preferences toward organic and antibiotic-free products can challenge traditional anticoccidial strategies. Producers may need to adapt their practices to meet these preferences, requiring investment in new, compliant solutions.

In conclusion, the anticoccidial drug market is driven by rising poultry production, growing awareness of animal health, regulatory support for alternatives, technological advancements, and increased investment in R&D. However, challenges such as regulatory hurdles, market saturation, and shifting consumer preferences must be addressed. Understanding these dynamics will help stakeholders navigate the complexities of the market and seize growth opportunities.

List of Anticoccidial Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies anticoccidial drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the anticoccidial drug companies profiled in this report include-

  • Zoetis
  • Phibro Animal Health Corporation
  • Huvepharma
  • Elanco
  • Biochem Pharma
  • Ceva
  • Impextraco
  • Virbac
  • Boehringer Ingelheim International
  • MSD Animal Health

Anticoccidial Drug by Segment

The study includes a forecast for the global anticoccidial drug market by animal, drug action, drug class, distribution channel, and region.

Anticoccidial Drug Market by Animal [Analysis by Value from 2019 to 2031]:

  • Livestock Animals
  • Companion Animals

Anticoccidial Drug Market by Drug Action [Analysis by Value from 2019 to 2031]:

  • Coccidiostatic
  • Coccidiocidal

Anticoccidial Drug Market by Drug Class [Analysis by Value from 2019 to 2031]:

  • Ionophore
  • Antibiotic
  • Sulphonamides
  • Chemical Derivative
  • Others

Anticoccidial Drug Market by Distribution Channel [Analysis by Value from 2019 to 2031]:

  • Veterinary Hospitals
  • Retail Pharmacy
  • Others

Anticoccidial Drug Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Anticoccidial Drug Market

The anticoccidial drug market is witnessing significant advancements driven by increasing poultry production, rising awareness of animal health, and regulatory changes. Key players are focusing on innovative formulations and alternative therapies to combat drug resistance and improve efficacy. Countries like the United States, China, Germany, India, and Japan are experiencing varied developments influenced by local market demands, regulatory frameworks, and agricultural practices. Understanding these regional dynamics can provide insights into the ultimate trajectory of the global anticoccidial market.

  • United States: The U.S. market is seeing a shift toward natural and organic anticoccidials, driven by consumer demand for antibiotic-free poultry. Regulatory bodies are also encouraging alternatives to traditional chemicals to enhance animal welfare.
  • China: Rapid growth in poultry farming has prompted Chinese companies to invest in R&D for new anticoccidial agents, focusing on improving efficacy and reducing side effects. Government support for innovative agriculture further boosts these initiatives.
  • Germany: In Germany, stringent regulations on antibiotic use are prompting the development of new anticoccidial drugs with lower resistance profiles. Research institutions collaborate with pharmaceutical companies to enhance product safety and effectiveness.
  • India: The Indian anticoccidial market is expanding due to increasing poultry consumption and investment in animal health. Local manufacturers are developing cost-effective solutions while also exploring herbal and alternative treatments.
  • Japan: The Japanese market is characterized by advanced formulations that aim to reduce environmental impact. The focus on sustainability drives the development of plant-based anticoccidials, aligning with consumer preferences for eco-friendly products.

Features of the Global Anticoccidial Drug Market

Market Size Estimates: Anticoccidial drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Anticoccidial drug market size by various segments, such as by animal, drug action, drug class, distribution channel, and region in terms of value ($B).

Regional Analysis: Anticoccidial drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different animals, drug actions, drug classes, distribution channels, and regions for the anticoccidial drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the anticoccidial drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the anticoccidial drug market by animal (livestock animals and companion animals), drug action (coccidiostatic and coccidiocidal), drug class (ionophore, antibiotic, sulphonamides, chemical derivative, and others), distribution channel (veterinary hospitals, retail pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Anticoccidial Drug Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Anticoccidial Drug Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Anticoccidial Drug Market by Animal
    • 3.3.1: Livestock Animals
    • 3.3.2: Companion Animals
  • 3.4: Global Anticoccidial Drug Market by Drug Action
    • 3.4.1: Coccidiostatic
    • 3.4.2: Coccidiocidal
  • 3.5: Global Anticoccidial Drug Market by Drug Class
    • 3.5.1: Ionophore
    • 3.5.2: Antibiotic
    • 3.5.3: Sulphonamides
    • 3.5.4: Chemical Derivative
    • 3.5.5: Others
  • 3.6: Global Anticoccidial Drug Market by Distribution Channel
    • 3.6.1: Veterinary Hospitals
    • 3.6.2: Retail Pharmacy
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Anticoccidial Drug Market by Region
  • 4.2: North American Anticoccidial Drug Market
    • 4.2.1: North American Market by Animal: Livestock Animals and Companion Animals
    • 4.2.2: North American Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others
  • 4.3: European Anticoccidial Drug Market
    • 4.3.1: European Market by Animal: Livestock Animals and Companion Animals
    • 4.3.2: European Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others
  • 4.4: APAC Anticoccidial Drug Market
    • 4.4.1: APAC Market by Animal: Livestock Animals and Companion Animals
    • 4.4.2: APAC Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others
  • 4.5: ROW Anticoccidial Drug Market
    • 4.5.1: ROW Market by Animal: Livestock Animals and Companion Animals
    • 4.5.2: ROW Market by Distribution Channel: Veterinary Hospitals, Retail Pharmacy, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Anticoccidial Drug Market by Animal
    • 6.1.2: Growth Opportunities for the Global Anticoccidial Drug Market by Drug Action
    • 6.1.3: Growth Opportunities for the Global Anticoccidial Drug Market by Drug Class
    • 6.1.4: Growth Opportunities for the Global Anticoccidial Drug Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Anticoccidial Drug Market by Region
  • 6.2: Emerging Trends in the Global Anticoccidial Drug Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Anticoccidial Drug Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Anticoccidial Drug Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Zoetis
  • 7.2: Phibro Animal Health Corporation
  • 7.3: Huvepharma
  • 7.4: Elanco
  • 7.5: Biochem Pharma
  • 7.6: Ceva
  • 7.7: Impextraco
  • 7.8: Virbac
  • 7.9: Boehringer Ingelheim International
  • 7.10: MSD Animal Health